Targeted Care Cream

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Glycerin fills a polyol-humectant role in the listed cosmetic formats. Read its percentage as formulation guidance, not an assay.

3. Typical use levels (formulation guide)

• Gels and serums: 3–8%.
• The guide range for creams is 2–5% in this reference.
• The formulation record indicates 2–4% for rinse-off.

Add Glycerin in the water phase without melting it first.

4. Regulatory sources & global compliance

• CosIng information about Glycerin does not itself authorize a particular grade or finished cosmetic.
• The framework in Regulation (EC) No 1223/2009 requires an assessment addressing the safety of the finished product that contains Glycerin at the level of the finished cosmetic product.
• Compare the received Glycerin material with its supplier specification and review destination-market filing needs.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; it does not authorize a drug or OTC product and the completed formula still requires stability and patch testing.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; where oxidation is a concern, evaluate airless or pump packaging; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The cosmetic role of Glycerin is presented as humectant function.

• This product entry provides no basis for therapeutic results, cure claims, or unverified certification claims.
• The cosmetic guidance for Glycerin provides no basis for skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• Formulation guidance for gel-creams: 2–6%.
• For dry oils, use 10–30% in this reference.
• Balms may use the guide range 5–15% in this reference.

Incorporate Squalane in the oil phase without a separate high-shear wax step.

4. Regulatory sources & global compliance

• CosIng information about Squalane does not itself authorize a particular grade or finished cosmetic.
• Regulation (EC) No 1223/2009 requires a safety evaluation of the product containing Squalane as it will be marketed before the finished product is marketed.
• Check the supplier's technical information for the Squalane grade and confirm the relevant market filing list.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; it does not establish drug approval or OTC-monograph status with patch and stability testing still needed for the completed formula.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Squalane in a direction centered on a light-emollient role.

• The ingredient guidance does not substantiate claims of drug activity, a clinical cure, or an undocumented product certification.
• This reference for Squalane should not be cited in support of whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

Shea butter is the triglyceride butter used for cushion in creams, balms, and hair creams. The guide does not assume an unrefined color or scent.

3. Typical use levels (formulation guide)

• The formulation record indicates 2–8% for creams in this reference.
• Formulation guidance for balms and butters: 10–25% as a formulation guide.

For Butyrospermum Parkii Butter, use an oil-phase melt and shear during cool-down to limit grain formation.

4. Regulatory sources & global compliance

• CosIng information about Butyrospermum Parkii Butter does not itself authorize a particular grade or finished cosmetic.
• Regulation (EC) No 1223/2009 sets the requirement for an assessment of the safety of the final cosmetic containing Butyrospermum Parkii Butter for the product in its final form.
• Establish grade-specific details for Butyrospermum Parkii Butter from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

This level is a cosmetic-formulation guide; it does not authorize a drug or OTC product so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; review airless or pump options if oxidation presents a concern; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic role of Butyrospermum Parkii Butter is presented as shea cushion.

• The formulation note cannot verify claims of drug action or cure, or a product certification outside the supporting records.
• The ingredient record for Butyrospermum Parkii Butter offers no support for whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.